These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1242128

  • 1. Effects of CB-154 (2-Br-alpha-ergocryptine) on prolactin and growth hormone release in an acromegalic patient with galactorrhea.
    Ueda G, Sato Y, Yamasaki M, Shioji T, Aono T.
    Endocrinol Jpn; 1975 Jun; 22(3):265-8. PubMed ID: 1242128
    [Abstract] [Full Text] [Related]

  • 2. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM, Kletzky OA, Davajan V.
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [Abstract] [Full Text] [Related]

  • 3. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ, Josimovich JB, Archer DF.
    Am J Obstet Gynecol; 1975 May 01; 122(1):85-9. PubMed ID: 1168997
    [Abstract] [Full Text] [Related]

  • 4. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
    Aono T, Shioji T, Kohno M, Ueda G, Kurachi K.
    Fertil Steril; 1976 Mar 01; 27(3):341-4. PubMed ID: 943332
    [Abstract] [Full Text] [Related]

  • 5. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G, Schonauer S, Lodico G, Lotti G, Delitala G, Masala A.
    Minerva Ginecol; 1976 Oct 01; 28(10):761-70. PubMed ID: 1036769
    [Abstract] [Full Text] [Related]

  • 6. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I, Kataoka K, Tomita A, Takanohashi M, Nakane T, Kuwayama A, Kageyama N.
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan 20; 55(1):16-24. PubMed ID: 581754
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE, Khojandi M, Huth J, Smith B, Thomas P.
    Am J Obstet Gynecol; 1975 Feb 01; 121(3):375-9. PubMed ID: 1115151
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP, Stone SC.
    Obstet Gynecol; 1976 Jul 01; 48(1):84-9. PubMed ID: 934580
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drugs that affect the breast and lactation.
    Dickey RP, Stone SC.
    Clin Obstet Gynecol; 1975 Jun 01; 18(2):95-111. PubMed ID: 1095275
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M, L'Hermite M, Hedouin-Quincampoix M, Fossati P.
    Acta Endocrinol (Copenh); 1977 Apr 01; 84(4):738-49. PubMed ID: 322432
    [Abstract] [Full Text] [Related]

  • 20. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
    Netter A, Netter AL, Gorins A.
    Gynecologie; 1975 Apr 01; 26(2):141-5. PubMed ID: 1164955
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.